Sodium valproate and 5-aza-2′-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells | Scientific Reports
DNA Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B | Molecular and Cellular Biology
5-Aza-2'-deoxycytidine | CAS:2353-33-5 | Deoxycytidine analog and cellular diifferentiation inducer | Alkaloids | High Purity | Manufacturer BioCrick
Intracellular metabolism of 5-AZA-CdR. 5-AZA-CdR is transported into... | Download Scientific Diagram
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo
Scheme 2. Preparation of the phosphoramidite of 5-aza-29-deoxycytidine.... | Download Scientific Diagram
Figure 1 from Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation. | Semantic Scholar
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers. - Abstract - Europe PMC
S110, a novel decitabine dinucleotide, increases fetal hemoglobin levels in baboons ( P. anubis ) | SpringerLink
Nucleosidic DNA demethylating epigenetic drugs – A comprehensive review from discovery to clinic - ScienceDirect
DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer | Anticancer Research
Adverse Effects of 5-Aza-2′-Deoxycytidine on Spermatogenesis Include Reduced Sperm Function and Selective Inhibition of de Novo DNA Methylation | Journal of Pharmacology and Experimental Therapeutics
Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells
Comparison of structures of cytidine, 5-aza-2-deoxycytidine,... | Download Scientific Diagram
The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo
5-Aza-2 -deoxycytidine = 97 2353-33-5
Frontiers | Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism | Oncology
Model to explain the effects of 5-aza-dC on DNA methylation and the... | Download Scientific Diagram
Azacitidine - Wikipedia
5,6 Dihydroazacitidine - an overview | ScienceDirect Topics
Pharmacology of 5-Aza-2′-deoxycytidine (decitabine) - ScienceDirect
Targeting DNA methylation for epigenetic therapy: Trends in Pharmacological Sciences
Induction of senescence in cancer cells by 5′-Aza-2′-deoxycytidine: Bioinformatics and experimental insights to its targets - ScienceDirect
Frontiers | Mechanisms of Action of Hypomethylating Agents: Endogenous Retroelements at the Epicenter | Oncology
